Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
22.84
+0.32 (1.40%)
Nov 6, 2025, 4:00 PM EST - Market closed
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $3.06 billion as of November 6, 2025. Its market cap has increased by 54.03% in one year.
Market Cap
3.06B
Enterprise Value
2.82B
1-Year Change
54.03%
Ranking
Category
Stock Price
$22.84
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $3.06B, an increase of 75.10%. That is a compound annual growth rate of 13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 3.06B | 38.63% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |